Bruce Rogers - Morphic Holding President Officer

President

Bruce Rogers is President Officer of Morphic Holding
Age 55
Phone781 996 0955
Webhttps://www.morphictx.com

Bruce Rogers Latest Insider Activity

Tracking and analyzing the buying and selling activities of Bruce Rogers against Morphic Holding stock is an integral part of due diligence when investing in Morphic Holding. Bruce Rogers insider activity provides valuable insight into whether Morphic Holding is net buyers or sellers over its current business cycle. Note, Morphic Holding insiders must abide by specific rules, including filing SEC forms every time they buy or sell Morphic Holding'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Morphic Holding Management Efficiency

The company has return on total asset (ROA) of (0.1909) % which means that it has lost $0.1909 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2669) %, meaning that it created substantial loss on money invested by shareholders. Morphic Holding's management efficiency ratios could be used to measure how well Morphic Holding manages its routine affairs as well as how well it operates its assets and liabilities.
Morphic Holding currently holds 2.34 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Morphic Holding has a current ratio of 20.25, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Morphic Holding's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 6 records

PRESIDENT Age

Andrew MBAVaxcyte
57
Gregory ZanteViking Therapeutics
53
Mark SmytheProtagonist Therapeutics
60
Erin MDTerns Pharmaceuticals
53
Suneel GuptaProtagonist Therapeutics
66
Ashok BhandariProtagonist Therapeutics
61
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Morphic Holding operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people. Morphic Holding (MORF) is traded on NASDAQ Exchange in USA and employs 128 people.

Management Performance

Morphic Holding Leadership Team

Elected by the shareholders, the Morphic Holding's board of directors comprises two types of representatives: Morphic Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Morphic. The board's role is to monitor Morphic Holding's management team and ensure that shareholders' interests are well served. Morphic Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Morphic Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
MD MBA, CFO COO
Farrell CPA, Sr Officer
Simon MBBS, Chief Officer
Joanne Gibbons, Senior Affairs
CPA Farrell, Senior Officer
Aaron Pelta, Senior Development
Dr MBA, Independent Founder
Bruce Rogers, President Officer
Praveen MD, MD CEO
Timothy Springer, Independent Founder
Blaise Lippa, Chief Officer
William Esq, General Secretary

Morphic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Morphic Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Consideration for investing in Morphic Stock

If you are still planning to invest in Morphic Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Morphic Holding's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins